Equities
Annexon presents vonaprument data at retina meeting
The biotech firm shared results from its Phase 2 and Phase 3 ARCHER programs for vonaprument, an investigational treatment for geographic atrophy, at The Retina Society annual meeting.
Trident Digital Regains Nasdaq Compliance After Market Value Recovery
Singapore-based digital infrastructure firm Trident Digital Tech Holdings exceeded Nasdaq’s $35 million market value threshold for 10 consecutive days, restoring its listing compliance after a prior violation.
Nuvectis’ NXP200 gains China breakthrough therapy designation for BRAF-mutant gliomas
Breakthrough Therapy Designation from China’s Center for Drug Evaluation accelerates development of oral BRAF inhibitor for recurrent high-grade gliomas, while Nuvectis plans U.S. IND submission in Q4 2026.
Elicio to Present Phase 2 Pancreatic Cancer Trial Data at ESMO 2026 Congress
The company will share results from its randomized Phase 2 AMPLIFY-7P study of ELI-002 7P in resected pancreatic cancer, which did not meet the primary disease‑free survival endpoint. Presentation is scheduled for Oct. 23, 2026, at the ESMO Congress in Madrid.
Qualcomm Renews Long-Term Patent Deal with Apple
A renewed licensing agreement helps ease Qualcomm’s revenue concerns amid Apple’s push for in-house chip production.
Collective Metals Appoints Curtis Riou to Board of Directors
The mining exploration firm adds Curtis Riou, a geoscientist with over 25 years in oil, gas and mining, to its board as it advances the Rocas uranium project in Saskatchewan.
HCW Biologics Prices $1.5 Million Private Placement Offering
The company issued 903,614 units at $1.6599 each to an existing stockholder, comprising pre-funded and common warrants, with proceeds earmarked for clinical trials and general corporate purposes.
Digital Brands’ Collegiate Brand AVO Posts 221% Revenue Growth
AVO’s e-commerce and licensing unit saw explosive growth amid reduced marketing spend and targeted university expansions.
AI-driven Tech Titans strategy posts 213% return since launch
The AI‑selected tech portfolio has generated over 213% total return and a 93% monthly hit rate, outpacing the S&P 500 while subscription costs stay under $9 per month.
Glucotrack prices $3.1 million public offering at $2.04 per share
The biotech company sold 169,388 shares of common stock at $2.04 each and issued pre‑funded warrants for up to 1,350,220 shares at $2.039 per warrant, raising approximately $3.1 million in gross proceeds before fees.
FBS Global Completes 1-for-10 Reverse Stock Split to Meet Nasdaq Listing Rules
Construction firm consolidates shares ten-to-one after shareholder approval to satisfy the exchange's $1.00 minimum bid price requirement.
US Stocks Face Pressure From Rising Oil and Bond Yields
Wall Street expects losses as oil prices climb on Middle East fears and 30-year Treasury yields hit levels not seen since 2004, weighing on technology shares.
Dextr AI Raises $6.7M to Scale Hotel AI Agents, Targeting Revenue Growth and Cost Savings
San Francisco-based Dextr AI, founded in July 2025, secures $6.7M seed funding to expand its AI-driven hotel agents, which boost revenue through bookings and cut operational costs by automating guest interactions and staff coordination.
Krait Critical Minerals Closes First Tranche of $1.22 Million Private Placement
The company issued 1.63 million common shares at $0.75 each for gross proceeds of $1.22 million, paid finder's fees and issued warrants, and expects a second tranche next week to fund exploration at its Goldbar Spider Lake project and evaluation of Nevada Hills antimony assets.
Ming Yang Smart Energy to Cancel 70 Million Shares in Capital Reduction
The board approved canceling 70 million repurchased A-shares previously earmarked for employee stock plans, cutting total share capital by roughly 3.1%.
UBS Upgrades Glencore to Buy, Raises Target to 650 Pence
The bank lifted its 12-month target on the miner from 620p and boosted 2026–27 EBITDA estimates, citing commodity strength and improving earnings visibility despite an ongoing legal dispute.
Oxford Biomedica chair buys 20,250 shares at £5.05 each
Chairman Dr. Roch Doliveux purchased 20,250 Oxford Biomedica shares for £5.05 per share on Sept. 23, bringing his total holding to 459,055 shares (0.379%).
SOS Ltd. Holds $75.6M in Digital Assets, Eyes 500MW Data Center
SOS Limited reported crypto holdings of roughly $75.6 million and disclosed a nonbinding framework to develop a major AI and cloud data center campus in Indonesia.
ARK Invest Tokenizes Venture Fund With OpenAI, Anthropic Stakes on Ethereum
Cathie Wood's firm partners with Securitize to put its ARKVX fund on blockchain rails, expanding beyond earlier tokenized Treasury products into private-market equities.
Oracle invokes force majeure on $165bn Project Jupiter data center
Oracle cited a force‑majeure clause after pipeline delays threatened its 2.45 GW, $165 billion Project Jupiter data‑center in New Mexico, sending the stock down about 4%.
BlackBerry Q2 FY27: QNX hits record, Alloy Kore wins major automotive deal
Revenue surged 26% year-over-year to $163 million, while adjusted EBITDA rose 29% to $47 million as QNX and licensing segments drove growth.
Michael Page Names Paul Harrison as Next Chairman
Michael Page plc has appointed Paul Harrison as chair-designate, succeeding Angela Seymour-Jackson when she steps down after the 2027 annual general meeting.
Cycurion Sees $843K From Chicago Public Safety Contracts in 2026
The Nasdaq-listed cybersecurity firm forecast roughly $843,028 in revenue from Chicago public safety engagements in calendar 2026, including a CAD administration role projected at $3.43 million over a decade.
EOG Resources Names New CFO, Ann Janssen Retires
EOG Resources, Inc. announced the appointment of Jeffrey Hibbard as chief financial officer and the retirement of Ann Janssen after more than three decades at the company.
